Table 1.
Patient and procedural characteristics.
| Characteristics | Pts./Events | Percentage |
|---|---|---|
| Sex | ||
| Male | 17 | 71.0% |
| Female | 7 | 29.0% |
| Age (years) | ||
| Median | 65.6 | |
| Range | 52–78 | |
| Previous treatments of patients per study group | ||
| GROUP I—Previous unsuccessful local ablative techniques | 5 | 20.9% |
| RFA | 1 | 4.2 |
| TACE | 2 | 8.3% |
| RFA + TACE | 1 | 4.2% |
| MWA + TACE | 1 | 4.2% |
| GROUP II—Only palliative treatment could be offered | 17 | 70.8% |
| None | 17 | 70.8% |
| GROUP III—Bridging therapy to transplantation | 2 | 8.4% |
| None | 1 | 4.2% |
| Surgery | 1 | 4.2% |
| Child-Pugh score | ||
| A (median score 5) | 14 | 58.3% |
| score 5 | 9 | |
| score 6 | 5 | |
| B (median score 7) | 9 | 37.5% |
| score 7 | 7 | |
| score 8 | 2 | |
| Esophageal varices | 10 | 41.7% |
| BCLC stage | ||
| 0 | 1 | 4.2% |
| A | 7 | 29.2% |
| B | 16 | 66.6% |
| ASA score | ||
| ASA 2 | 6 | 25.0% |
| ASA 3 | 18 | 75.0% |
| Number of tumors treated | ||
| Total | 32 | |
| Average per patient | 1.3 | |
| Range | 1–4 | |
| Tumor size | ||
| Average | 2.5 cm | |
| Range | 0.8–4.5 cm | |
| Type of electrodes used in ECT | ||
| Fixed geometry | 23 | 71.9% |
| Variable geometry | 9 | 28.1% |
RFA—radiofrequency ablation; MWA—microwave ablation; TACE—transarterial chemoembolization; BCLC—Barcelona Clinic Liver Cancer classification.